Business Insider

ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label

Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of age to receive neffy 1 mg dose - approval enables families of younger ...
Monthly Prescribing Reference

FDA Warns Clinicians Not to Confuse Epinephrine Products Due to Similar Packaging

Epinephrine nasal solutions from BPI Labs and Endo USA should not be used, according to the FDA. Similarities between the packaging for certain intranasal and intravenous epinephrine products may ...
Healio

Dry powder epinephrine nasal spray outcomes comparable with intramuscular injection

Please provide your email address to receive an email when new articles are posted on . Subjects had two doses each of Belhaven Biopharma’s BBP01 and intramuscular epinephrine. Subjects had faster and ...

ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label

Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of age to receive neffy 1 mg dose ...
Finanznachrichten

ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy 1 mg (epinephrine nasal spray) Label

Children were previously required to weigh =33 lbs. and 66 lbs. and be at least four years of age to receive neffy 1 mg dose - approval enables families of younger ...